Clinical trial
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye…
NCT00198536 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198536 |
|---|---|
| Title | Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome |
| Official title | Efficacy and Safety of Ecabet Ophthalmic Solution (2.83% and 3.70%) for Treatment of Dry Eye Syndrome |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Dry Eye Syndromes |
| Intervention type | Drug |
| Interventions | Ecabet 2.83%, Ecabet 3.70%, Vehicle |
| Enrollment | 159 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: